BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 9499416)

  • 21. Combined translocation with ZNF198-FGFR1 gene fusion and deletion of potential tumor suppressors in a myeloproliferative disorder.
    Etienne A; Gelsi-Boyer V; Carbuccia N; Adélaïde J; Barba G; La Starza R; Murati A; Eclache V; Birg F; Birnbaum D; Mozziconacci MJ; Mecucci C; Chaffanet M
    Cancer Genet Cytogenet; 2007 Mar; 173(2):154-8. PubMed ID: 17321332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myeloproliferative neoplasms with t(8;22)(p11.2;q11.2)/BCR-FGFR1: a meta-analysis of 20 cases shows cytogenetic progression with B-lymphoid blast phase.
    Montenegro-Garreaud X; Miranda RN; Reynolds A; Tang G; Wang SA; Yabe M; Wang W; Fang L; Bueso-Ramos CE; Lin P; Medeiros LJ; Lu X
    Hum Pathol; 2017 Jul; 65():147-156. PubMed ID: 28551329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a t(8;13)(p11;q11-12) in an atypical myeloproliferative disorder.
    Smedley D; Somers G; Venter D; Chow CW; Cooper C; Shipley J
    Genes Chromosomes Cancer; 1998 Jan; 21(1):70-3. PubMed ID: 9443043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a novel partner gene, TPR, fused to FGFR1 in 8p11 myeloproliferative syndrome.
    Li F; Zhai YP; Tang YM; Wang LP; Wan PJ
    Genes Chromosomes Cancer; 2012 Sep; 51(9):890-7. PubMed ID: 22619110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical and gene involved of one case of 8p11 myeloproliferative syndrome with ins(13;8)(q12;p11p23)].
    Zhou F; Chen S; Chao H; Zhang R; Zhou M; Pan J
    Zhonghua Xue Ye Xue Za Zhi; 2015 Apr; 36(4):291-6. PubMed ID: 25916288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct stem cell myeloproliferative/T lymphoma syndromes induced by ZNF198-FGFR1 and BCR-FGFR1 fusion genes from 8p11 translocations.
    Roumiantsev S; Krause DS; Neumann CA; Dimitri CA; Asiedu F; Cross NC; Van Etten RA
    Cancer Cell; 2004 Mar; 5(3):287-98. PubMed ID: 15050920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder.
    Chen J; Deangelo DJ; Kutok JL; Williams IR; Lee BH; Wadleigh M; Duclos N; Cohen S; Adelsperger J; Okabe R; Coburn A; Galinsky I; Huntly B; Cohen PS; Meyer T; Fabbro D; Roesel J; Banerji L; Griffin JD; Xiao S; Fletcher JA; Stone RM; Gilliland DG
    Proc Natl Acad Sci U S A; 2004 Oct; 101(40):14479-84. PubMed ID: 15448205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B-cell acute lymphoblastic leukemia as evolution of a 8p11 myeloproliferative syndrome with t(8;22)(p11;q11) and BCR-FGFR1 fusion gene.
    Baldazzi C; Iacobucci I; Luatti S; Ottaviani E; Marzocchi G; Paolini S; Stacchini M; Papayannidis C; Gamberini C; Martinelli G; Baccarani M; Testoni N
    Leuk Res; 2010 Oct; 34(10):e282-5. PubMed ID: 20594995
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-term complete haematological and molecular remission after allogeneic bone marrow transplantation in a patient with a stem cell myeloproliferative disorder associated with t(8;13)(p12;q12).
    Suzan F; Guasch G; Terre C; Garcia I; Bastie JN; Maarek O; Ribaud P; Gluckman E; Daniel MT; Pébusque MJ; Castaigne S
    Br J Haematol; 2003 Apr; 121(2):312-4. PubMed ID: 12694254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fusion gene-mediated truncation of RUNX1 as a potential mechanism underlying disease progression in the 8p11 myeloproliferative syndrome.
    Agerstam H; Lilljebjörn H; Lassen C; Swedin A; Richter J; Vandenberghe P; Johansson B; Fioretos T
    Genes Chromosomes Cancer; 2007 Jul; 46(7):635-43. PubMed ID: 17394134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fusion of H4/D10S170 to the platelet-derived growth factor receptor beta in BCR-ABL-negative myeloproliferative disorders with a t(5;10)(q33;q21).
    Kulkarni S; Heath C; Parker S; Chase A; Iqbal S; Pocock CF; Kaeda J; Cwynarski K; Goldman JM; Cross NC
    Cancer Res; 2000 Jul; 60(13):3592-8. PubMed ID: 10910073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ZNF198 protein, involved in rearrangement in myeloproliferative disease, forms complexes with the DNA repair-associated HHR6A/6B and RAD18 proteins.
    Kunapuli P; Somerville R; Still IH; Cowell JK
    Oncogene; 2003 May; 22(22):3417-23. PubMed ID: 12776193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FGFR1 is fused to the centrosome-associated protein CEP110 in the 8p12 stem cell myeloproliferative disorder with t(8;9)(p12;q33).
    Guasch G; Mack GJ; Popovici C; Dastugue N; Birnbaum D; Rattner JB; Pébusque MJ
    Blood; 2000 Mar; 95(5):1788-96. PubMed ID: 10688839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular monitoring of 8p11 myeloproliferative syndrome in an infant.
    Zhang WW; Habeebu S; Sheehan AM; Naeem R; Hernandez VS; Dreyer ZE; López-Terrada D
    J Pediatr Hematol Oncol; 2009 Nov; 31(11):879-83. PubMed ID: 19829149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FOP-FGFR1 tyrosine kinase, the product of a t(6;8) translocation, induces a fatal myeloproliferative disease in mice.
    Guasch G; Delaval B; Arnoulet C; Xie MJ; Xerri L; Sainty D; Birnbaum D; Pébusque MJ
    Blood; 2004 Jan; 103(1):309-12. PubMed ID: 12969958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tyrosine kinase fusion genes in chronic myeloproliferative diseases.
    Cross NC; Reiter A
    Leukemia; 2002 Jul; 16(7):1207-12. PubMed ID: 12094244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A further case of myeloproliferative syndrome with reciprocal translocation (8;13)(p11;q12).
    Invernizzi R; Benatti C; Travaglino E; Girino M; Bernasconi P; Loni C; Ascari E
    Haematologica; 2004 Feb; 89(2):239-41. PubMed ID: 15003903
    [No Abstract]   [Full Text] [Related]  

  • 38. A fourth case of BCR-FGFR1 positive CML-like disease with t(8;22) translocation showing an extensive deletion on the derivative chromosome 8p.
    Pini M; Gottardi E; Scaravaglio P; Giugliano E; Libener R; Baraldi A; Muzio A; Cornaglia E; Saglio G; Levis A
    Hematol J; 2002; 3(6):315-6. PubMed ID: 12522455
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical variability of patients with the t(6;8)(q27;p12) and FGFR1OP-FGFR1 fusion: two further cases.
    Vizmanos JL; Hernández R; Vidal MJ; Larráyoz MJ; Odero MD; Marín J; Ardanaz MT; Calasanz MJ; Cross NC
    Hematol J; 2004; 5(6):534-7. PubMed ID: 15570299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 8p11 myeloproliferative syndrome preceded by t(8;9)(p11;q33), CEP110/FGFR1 fusion transcript: morphologic, molecular, and cytogenetic characterization of myeloid neoplasms associated with eosinophilia and FGFR1 abnormality.
    Park TS; Song J; Kim JS; Yang WI; Song S; Kim SJ; Suh B; Choi JR
    Cancer Genet Cytogenet; 2008 Mar; 181(2):93-9. PubMed ID: 18295660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.